Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
Houweling AC, Gijezen LM, Jonker MA, van Doorn MB, Oldenburg RA, van Spaendonck-Zwarts KY, Leter EM, van Os TA, van Grieken NC, Jaspars EH, de Jong MM, Bongers EM, Johannesma PC, Postmus PE, van Moorselaar RJ, van Waesberghe JH, Starink TM, van Steensel MA, Gille JJ, Menko FH. Houweling AC, et al. Among authors: de jong mm. Br J Cancer. 2011 Dec 6;105(12):1912-9. doi: 10.1038/bjc.2011.463. Br J Cancer. 2011. PMID: 22146830 Free PMC article.
No association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.
de Jong MM, Hofstra RM, Kooi KA, Westra JL, Berends MJ, Wu Y, Hollema H, van der Sluis T, van der Graaf WT, de Vries EG, Schaapveld M, Sijmons RH, te Meerman GJ, Kleibeuker JH. de Jong MM, et al. Among authors: de vries eg. Cancer Genet Cytogenet. 2004 Jul 1;152(1):70-1. doi: 10.1016/j.cancergencyto.2003.10.008. Cancer Genet Cytogenet. 2004. PMID: 15193445
Colorectal cancer and the CHEK2 1100delC mutation.
de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G, Bruinenberg M, Schaapveld M, Niessen RC, Berends MJ, Sijmons RH, Hofstra RM, de Vries EG, Kleibeuker JH. de Jong MM, et al. Among authors: de vries eg. Genes Chromosomes Cancer. 2005 Aug;43(4):377-82. doi: 10.1002/gcc.20195. Genes Chromosomes Cancer. 2005. PMID: 15852425
Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
van der Tuin K, Mensenkamp AR, Tops CMJ, Corssmit EPM, Dinjens WN, van de Horst-Schrivers ANA, Jansen JC, de Jong MM, Kunst HPM, Kusters B, Leter EM, Morreau H, van Nesselrooij BMP, Oldenburg RA, Spruijt L, Hes FJ, Timmers HJLM. van der Tuin K, et al. Among authors: de jong mm. J Clin Endocrinol Metab. 2018 Feb 1;103(2):438-445. doi: 10.1210/jc.2017-01762. J Clin Endocrinol Metab. 2018. PMID: 29177515
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.
Bakhuizen JJ, Hogervorst FB, Velthuizen ME, Ruijs MW, van Engelen K, van Os TA, Gille JJ, Collée M, van den Ouweland AM, van Asperen CJ, Kets CM, Mensenkamp AR, Leter EM, Blok MJ, de Jong MM, Ausems MG. Bakhuizen JJ, et al. Among authors: de jong mm. Fam Cancer. 2019 Apr;18(2):273-280. doi: 10.1007/s10689-018-00118-0. Fam Cancer. 2019. PMID: 30607672
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Oosterom E, Bruinenberg M, Steege Gv, Oosterwijk JC, van der Hout AH, Boezen HM, Schaapveld M, Kleibeuker JH, de Vries EG. de Jong MM, et al. Among authors: de vries eg. Eur J Cancer. 2005 Aug;41(12):1819-23. doi: 10.1016/j.ejca.2005.04.035. Eur J Cancer. 2005. PMID: 16043347
We identified a risk haplotype in the HLA class III region in breast cancer patients [de Jong MM, Nolte IM, de Vries EGE, et al. The HLA class III subregion is responsible for an increased breast cancer risk. ...
We identified a risk haplotype in the HLA class III region in breast cancer patients [de Jong MM, Nolte IM, de V …
60 results